Related Experiment Video
Updated: Jul 17, 2026

05:57
Blood Flow Imaging with Ultrafast Doppler
Published on: October 14, 2020
Getting your medical device cleared for marketing in the U.S
Summary
This session covers U.S. medical device marketing requirements, including 510(k) and PMA pathways. It details registration, listing, and import processes for domestic and foreign companies.
Area of Science:
- Regulatory Affairs
- Medical Device Compliance
Background:
- Navigating the U.S. Food and Drug Administration (FDA) regulatory landscape is complex for medical device manufacturers.
- Understanding specific clearance pathways is crucial for market access.
Purpose of the Study:
- To provide an overview of the medical device clearance and approval processes in the United States.
- To clarify the requirements for 510(k) and Premarket Approval (PMA) applications.
- To address the specific needs of foreign companies seeking to import medical devices into the U.S.
Main Methods:
- Discussion group format facilitating interactive learning.
- Expert-led session with insights from former FDA officials and industry consultants.
- Sharing of practical experiences and addressing participant questions.
Main Results:
- Clarification of the 510(k) and PMA pathways for medical device marketing.
- Understanding of FDA registration and listing requirements.
- Insights into regulatory considerations for international medical device companies.
Conclusions:
- Successful medical device commercialization in the U.S. requires a thorough understanding of regulatory pathways.
- Preparation and adherence to FDA guidelines are essential for both domestic and foreign entities.
- Interactive discussions enhance knowledge and preparedness for regulatory compliance.
Related Concept Videos
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
